Effectiveness of Selective Digestive Decolonization Therapy Using Oral Gentamicin for Eradication of Carbapenem-resistant Enterobacteriaceae Carriage

Overview

Journal Infect Control Hosp Epidemiol

Publisher Cambridge University Press

Specialties Health Services
Infectious Diseases
Nursing
Public Health

Date 2022 Feb 9

PMID 35135653

Authors

So Yeon Park

Jin Seo Lee

Jihyu Oh

Seo Hu Lee

Jion Jung

Affiliations

Soon will be listed here.

Abstract

Objectives: To evaluate the efficacy of selective digestive decolonization (SDD) therapy using oral gentamicin against carbapenem-resistant Enterobacteriaceae (CRE) colonization and to compare the incidence of novel gentamicin resistance between SDD and non-SDD patient groups.

Design: Retrospective cohort study.

Setting: Acute-care referral center hospital in South Korea.

Methods: Adults aged ≥20 years identified as rectal CRE carriers hospitalized between October 2019 and June 2020 were enrolled. Patients with a <30-day follow-up were excluded. Among CRE carriers, those who received 80 mg oral gentamicin sulfate (Shin Poong Pharmaceutical, Seoul, South Korea) 4 times daily comprised the SDD group and those who did not receive SDD therapy comprised the non-SDD group. CRE decolonization was compared between groups within 15 days, and new gentamicin resistance was assessed.

Results: In total, 73 rectal CRE carriers were identified; 11 patients were lost to follow-up within 30 days and were excluded. Oral gentamicin was administered to 20 of 62 patients. We detected no differences in the basic demographic features between groups. The rate of decolonization within 15 days was higher in the SDD group than in the non-SDD group (70.0% vs 23.8%; = .001). The time to decolonization was significantly shorter in the SDD group. We detected no difference in acquisition of new gentamicin resistance between the groups. No serious adverse events due to oral gentamicin SDD therapy were reported.

Conclusions: SDD therapy using oral gentamicin for CRE-colonized patients may be effective for the decolonization of gut CRE and for the prevention of transmission and subsequent CRE infection.

Citing Articles

Structural Equation Modelling as a Proof-of-Concept Tool for Mediation Mechanisms Between Topical Antibiotic Prophylaxis and Six Types of Blood Stream Infection Among ICU Patients.

Hurley J Antibiotics (Basel). 2024; 13(11).

PMID: 39596789 PMC: 11591272. DOI: 10.3390/antibiotics13111096.

Decolonization strategies for ESBL-producing or carbapenem-resistant Enterobacterales carriage: a systematic review and meta-analysis.

Zhang H, Wang H, Tian F, Yang C, Zhao M, Ding Y Sci Rep. 2024; 14(1):24349.

PMID: 39420082 PMC: 11487172. DOI: 10.1038/s41598-024-75791-6.

References

Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O . Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2011; 18(1):54-60. DOI: 10.1111/j.1469-0691.2011.03478.x. View

Nordmann P, Naas T, Poirel L . Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011; 17(10):1791-8. PMC: 3310682. DOI: 10.3201/eid1710.110655. View

Lubbert C, Faucheux S, Becker-Rux D, Laudi S, Durrbeck A, Busch T . Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents. 2013; 42(6):565-70. DOI: 10.1016/j.ijantimicag.2013.08.008. View

Tascini C, Sbrana F, Flammini S, Tagliaferri E, Arena F, Leonildi A . Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: relevance of concomitant systemic antibiotic therapy. Antimicrob Agents Chemother. 2014; 58(4):1972-6. PMC: 4023775. DOI: 10.1128/AAC.02283-13. View

McConville T, Sullivan S, Gomez-Simmonds A, Whittier S, Uhlemann A . Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study. PLoS One. 2017; 12(10):e0186195. PMC: 5638409. DOI: 10.1371/journal.pone.0186195. View

Tumbarello M, Viale P, Viscoli C, Trecarichi E, Tumietto F, Marchese A . Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012; 55(7):943-50. DOI: 10.1093/cid/cis588. View

Arena F, Vannetti F, Di Pilato V, Fabbri L, Colavecchio O, Giani T . Diversity of the epidemiology of carbapenemase-producing Enterobacteriaceae in long-term acute care rehabilitation settings from an area of hyperendemicity, and evaluation of an intervention bundle. J Hosp Infect. 2018; 100(1):29-34. DOI: 10.1016/j.jhin.2018.05.025. View

Zuckerman T, Benyamini N, Sprecher H, Fineman R, Finkelstein R, Rowe J . SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state. Bone Marrow Transplant. 2010; 46(9):1226-30. DOI: 10.1038/bmt.2010.279. View

Giani T, Tascini C, Arena F, Ciullo I, Conte V, Leonildi A . Rapid detection of intestinal carriage of Klebsiella pneumoniae producing KPC carbapenemase during an outbreak. J Hosp Infect. 2012; 81(2):119-22. DOI: 10.1016/j.jhin.2012.04.004. View

10.

Tischendorf J, Avila R, Safdar N . Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review. Am J Infect Control. 2016; 44(5):539-43. PMC: 5262497. DOI: 10.1016/j.ajic.2015.12.005. View

11.

Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R . Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol. 2009; 30(10):972-6. DOI: 10.1086/605922. View

12.

Zhao Z, Xu X, Liu M, Wu J, Lin J, Li B . Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. Am J Infect Control. 2014; 42(5):e61-4. DOI: 10.1016/j.ajic.2014.01.024. View

13.

Oren I, Sprecher H, Finkelstein R, Hadad S, Neuberger A, Hussein K . Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial. Am J Infect Control. 2013; 41(12):1167-72. DOI: 10.1016/j.ajic.2013.04.018. View

14.

Zimmerman F, Assous M, Bdolah-Abram T, Lachish T, Yinnon A, Wiener-Well Y . Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control. 2013; 41(3):190-4. DOI: 10.1016/j.ajic.2012.09.020. View

15.

van Duin D, Kaye K, Neuner E, Bonomo R . Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis. 2013; 75(2):115-20. PMC: 3947910. DOI: 10.1016/j.diagmicrobio.2012.11.009. View

16.

Machuca I, Gutierrez-Gutierrez B, Perez Cortes S, Gracia-Ahufinger I, Serrano J, Madrigal M . Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2016; 71(11):3242-3249. DOI: 10.1093/jac/dkw272. View

17.

Tomczyk S, Zanichelli V, Grayson M, Twyman A, Abbas M, Pires D . Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies. Clin Infect Dis. 2018; 68(5):873-884. PMC: 6389314. DOI: 10.1093/cid/ciy752. View

18.

Banach D, Francois J, Blash S, Patel G, Jenkins S, LaBombardi V . Active surveillance for carbapenem-resistant Enterobacteriaceae using stool specimens submitted for testing for Clostridium difficile. Infect Control Hosp Epidemiol. 2013; 35(1):82-4. PMC: 3984911. DOI: 10.1086/674391. View

19.

Lubbert C, Lippmann N, Busch T, Kaisers U, Ducomble T, Eckmanns T . Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany. Am J Infect Control. 2014; 42(4):376-80. DOI: 10.1016/j.ajic.2013.12.001. View

20.

Schechner V, Kotlovsky T, Kazma M, Mishali H, Schwartz D, Navon-Venezia S . Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?. Clin Microbiol Infect. 2012; 19(5):451-6. DOI: 10.1111/j.1469-0691.2012.03888.x. View